Europe Generic Drug Market Size, CAGR, Share, Segment and Forecast 2023-2028

According to IMARC Group's latest report, titled "𝐄𝐮𝐫𝐨𝐩𝐞 𝐆𝐞𝐧𝐞𝐫𝐢𝐜 𝐃𝐫𝐮𝐠 𝐌𝐚𝐫𝐤𝐞𝐭: 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐓𝐫𝐞𝐧𝐝𝐬, 𝐒𝐡𝐚𝐫𝐞, 𝐒𝐢𝐳𝐞, 𝐆𝐫𝐨𝐰𝐭𝐡, 𝐎𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐲 𝐚𝐧𝐝 𝐅𝐨𝐫𝐞𝐜𝐚𝐬𝐭 𝟐𝟎𝟐𝟑-𝟐𝟎𝟐𝟖", the Europe generic drug market size reached US$ 56.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 89.1 Billion by 2028, exhibiting a growth rate (CAGR) of 7.6% during 2023-2028.

A generic drug is a medication that is equivalent to a brand-name drug in terms of dosage, strength, route of administration, quality, and intended use but is sold under a different name. Generic drugs are typically cheaper than brand-name drugs and are required to meet the same safety, efficacy, and quality standards as their brand-name counterparts. They are approved by regulatory agencies after demonstrating bioequivalence to the brand-name drug, meaning that they have the same active ingredients and work in the same way in the body. Generic drugs play a crucial role in making healthcare more affordable and accessible by providing cost-effective alternatives to brand-name drugs.

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐅𝐨𝐫 𝐚 𝐏𝐃𝐅 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭: https://www.imarcgroup.com/europe-generic-drug-market/requestsample

Note: We are in the process of updating our reports. If you want to receive the latest research data covering the period from 2023 to 2028, along with industry trends, market size, and competitive analysis, click on the request sample report. The team would be able to deliver the latest version of the report in a quick turnaround time.

𝐄𝐮𝐫𝐨𝐩𝐞 𝐆𝐞𝐧𝐞𝐫𝐢𝐜 𝐃𝐫𝐮𝐠 𝐌𝐚𝐫𝐤𝐞𝐭 𝐓𝐫𝐞𝐧𝐝𝐬:

The increasing prevalence of chronic diseases, such as diabetes, cardiovascular disorders, and cancer, represents a significant factor driving the market growth across Europe. In line with this, generic drugs provide cost-effective treatment options, thus driving the market growth. In addition to this, generic drugs are typically inexpensive than their brand-name counterparts, which, in turn, is contributing to the growth of the market. The market is also driven by governments of various nations across the region promoting the use of generic drugs through numerous favorable policies. Other factors, such as the increasing demand for healthcare reforms and rising number of patent expirations, are creating a positive outlook for the market across the region.

𝐁𝐮𝐲 𝐓𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 𝐍𝐨𝐰: https://www.imarcgroup.com/checkout?id=3276&method=1

Note: In this report you will get detailed analysis of the market, growth analysis graphs, historical period analysis, forecast period analysis, major market segmentation, top leading key players of the market, table of content, list of figures, and list of tables.

𝐊𝐞𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧:

The report has categorized the market based on segment, therapy area, drug delivery, distribution channel and region.

Breakup by Segment:
• Unbranded Generics
• Branded Generics

Breakup by Therapy Area:
• Central Nervous System
• Cardiovascular
• Dermatology
• Genitourinary/Hormonal
• Respiratory
• Rheumatology
• Diabetes
• Oncology
• Others

Breakup by Drug Delivery:
• Oral
• Injectables
• Dermal/Topical
• Inhalers

Breakup by Distribution Channel:
• Retail
• Hospital

Breakup by Country:
• Germany
• France
• United Kingdom
• Italy
• Spain
• Others

𝐂𝐨𝐦𝐩𝐞𝐭𝐢𝐭𝐢𝐯𝐞 𝐋𝐚𝐧𝐝𝐬𝐜𝐚𝐩𝐞:

The competitive landscape of the industry has also been examined along with the profiles of the key players.

𝘼𝙨𝙠 𝘼𝙣𝙖𝙡𝙮𝙨𝙩 𝙛𝙤𝙧 𝘾𝙪𝙨𝙩𝙤𝙢𝙞𝙯𝙖𝙩𝙞𝙤𝙣 𝙖𝙣𝙙 𝙇𝙞𝙨𝙩 𝙤𝙛 𝙁𝙞𝙜𝙪𝙧𝙚𝙨:
https://www.imarcgroup.com/request?type=report&id=3276&flag=C

𝐊𝐞𝐲 𝐇𝐢𝐠𝐡𝐥𝐢𝐠𝐡𝐭𝐬 𝐨𝐟 𝐓𝐡𝐞 𝐑𝐞𝐩𝐨𝐫𝐭:

• Market Performance (2017-2022)
• Market Outlook (2023-2028)
• Market Trends
• Market Drivers and Success Factors
• SWOT Analysis
• Value Chain Analysis
• Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

𝐑𝐞𝐥𝐚𝐭𝐞𝐝 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 𝐛𝐲 𝐈𝐌𝐀𝐑𝐂 𝐆𝐫𝐨𝐮𝐩:

https://www.einnews.com/pr_news/625764070/e-learning-market-forecast-2023-2028-size-us-582-3-billion-cagr-9-5-industry-report
https://www.einnews.com/pr_news/625767788/home-decor-market-size-cagr-share-by-companies-and-forcast-report-2023-2028
https://www.einnews.com/pr_news/625784313/food-grade-gases-market-size-growth-analysis-trends-and-forecast-2023-2028
https://www.einnews.com/pr_news/625790815/cloud-system-management-market-size-trends-top-players-and-forecast-2023-2028
https://www.einnews.com/pr_news/625800119/ceramic-tiles-market-size-to-reach-us-113-3-billion-by-2028-exhibiting-a-growth-rate-of-cagr-of-5-84

𝐌𝐞𝐝𝐢𝐚 𝐂𝐨𝐧𝐭𝐚𝐜𝐭:

Company Name: IMARC Group
Contact Person: Elena Anderson
Email: sales@imarcgroup.com
Phone: +1-631-791-1145
Address: 134 N 4th St
City: Brooklyn
State: NY
Country: United States
Website: https://www.imarcgroup.com/

𝐀𝐛𝐨𝐮𝐭 𝐔𝐬:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

This release was published on openPR.